Robert Burns
Stock Analyst at HC Wainwright & Co.
(3.87)
# 619
Out of 5,165 analysts
489
Total ratings
42.7%
Success rate
11.7%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Robert Burns
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OKUR OnKure Therapeutics | Maintains: Buy | $34 → $27 | $3.91 | +590.52% | 5 | Mar 16, 2026 | |
| MOLN Molecular Partners AG | Reiterates: Buy | $13 | $4.34 | +199.54% | 3 | Mar 16, 2026 | |
| ELTX Elicio Therapeutics | Maintains: Buy | $13 → $17 | $12.16 | +39.80% | 9 | Mar 13, 2026 | |
| ORIC ORIC Pharmaceuticals | Reiterates: Buy | $25 | $12.22 | +104.58% | 28 | Mar 13, 2026 | |
| BOLT Bolt Biotherapeutics | Reiterates: Buy | $7 | $4.54 | +54.19% | 2 | Mar 13, 2026 | |
| AKTS Aktis Oncology | Initiates: Buy | $30 | $19.77 | +51.75% | 1 | Mar 9, 2026 | |
| AVBP ArriVent BioPharma | Maintains: Buy | $42 → $44 | $24.31 | +81.00% | 12 | Mar 6, 2026 | |
| BBOT BridgeBio Oncology Therapeutics | Maintains: Buy | $27 → $29 | $9.11 | +218.51% | 2 | Mar 6, 2026 | |
| TNGX Tango Therapeutics | Maintains: Buy | $13 → $27 | $17.88 | +51.01% | 13 | Mar 6, 2026 | |
| ZYME Zymeworks | Maintains: Buy | $32 → $46 | $23.62 | +94.75% | 24 | Mar 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $8.55 | +75.44% | 4 | Feb 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $52 → $54 | $41.07 | +31.48% | 15 | Feb 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $2.10 | +376.19% | 5 | Feb 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $12 | $5.22 | +129.89% | 6 | Jan 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $31 → $32 | $15.38 | +108.06% | 21 | Jan 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $1.90 | +426.32% | 4 | Jan 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $50 | $7.17 | +597.35% | 3 | Jan 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $7.87 | +154.13% | 4 | Jan 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $18 → $17 | $4.50 | +277.78% | 18 | Jan 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $26 → $27 | $14.03 | +92.44% | 4 | Jan 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50 → $52 | $35.68 | +45.74% | 16 | Jan 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $12 | $10.77 | +11.42% | 10 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $136 → $140 | $90.54 | +54.63% | 46 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $72 → $73 | $99.00 | -26.26% | 21 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $9 | $1.87 | +381.28% | 15 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $2 | $3.10 | -35.48% | 22 | Nov 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $5 | $1.16 | +331.03% | 8 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $12 | $7.36 | +63.04% | 20 | Oct 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $7 | $4.22 | +65.88% | 22 | Oct 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $3.36 | +48.81% | 17 | Sep 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $14 | $10.13 | +38.20% | 22 | Aug 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $41 → $40 | $19.40 | +106.19% | 5 | Aug 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $10 | $2.19 | +356.62% | 14 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $48 | $27.39 | +75.25% | 5 | Jul 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $1.56 | +220.51% | 11 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $8 | $2.44 | +227.87% | 17 | Mar 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $5.87 | - | 13 | Jan 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $500 → $200 | $19.51 | +925.12% | 5 | May 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $1,320 → $240 | $0.32 | +73,974.07% | 2 | Mar 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $150 | $0.42 | +35,202.42% | 6 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $11 | $6.75 | +62.96% | 1 | Dec 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50,000 → $45,000 | $1.90 | +2,368,321.05% | 7 | Nov 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $13 | $1.51 | +760.93% | 1 | Jan 7, 2021 |
OnKure Therapeutics
Mar 16, 2026
Maintains: Buy
Price Target: $34 → $27
Current: $3.91
Upside: +590.52%
Molecular Partners AG
Mar 16, 2026
Reiterates: Buy
Price Target: $13
Current: $4.34
Upside: +199.54%
Elicio Therapeutics
Mar 13, 2026
Maintains: Buy
Price Target: $13 → $17
Current: $12.16
Upside: +39.80%
ORIC Pharmaceuticals
Mar 13, 2026
Reiterates: Buy
Price Target: $25
Current: $12.22
Upside: +104.58%
Bolt Biotherapeutics
Mar 13, 2026
Reiterates: Buy
Price Target: $7
Current: $4.54
Upside: +54.19%
Aktis Oncology
Mar 9, 2026
Initiates: Buy
Price Target: $30
Current: $19.77
Upside: +51.75%
ArriVent BioPharma
Mar 6, 2026
Maintains: Buy
Price Target: $42 → $44
Current: $24.31
Upside: +81.00%
BridgeBio Oncology Therapeutics
Mar 6, 2026
Maintains: Buy
Price Target: $27 → $29
Current: $9.11
Upside: +218.51%
Tango Therapeutics
Mar 6, 2026
Maintains: Buy
Price Target: $13 → $27
Current: $17.88
Upside: +51.01%
Zymeworks
Mar 6, 2026
Maintains: Buy
Price Target: $32 → $46
Current: $23.62
Upside: +94.75%
Feb 18, 2026
Reiterates: Buy
Price Target: $15
Current: $8.55
Upside: +75.44%
Feb 12, 2026
Maintains: Buy
Price Target: $52 → $54
Current: $41.07
Upside: +31.48%
Feb 3, 2026
Reiterates: Buy
Price Target: $10
Current: $2.10
Upside: +376.19%
Jan 30, 2026
Maintains: Buy
Price Target: $10 → $12
Current: $5.22
Upside: +129.89%
Jan 29, 2026
Maintains: Buy
Price Target: $31 → $32
Current: $15.38
Upside: +108.06%
Jan 28, 2026
Reiterates: Buy
Price Target: $10
Current: $1.90
Upside: +426.32%
Jan 21, 2026
Maintains: Buy
Price Target: $9 → $50
Current: $7.17
Upside: +597.35%
Jan 21, 2026
Reiterates: Buy
Price Target: $20
Current: $7.87
Upside: +154.13%
Jan 12, 2026
Maintains: Buy
Price Target: $18 → $17
Current: $4.50
Upside: +277.78%
Jan 8, 2026
Maintains: Buy
Price Target: $26 → $27
Current: $14.03
Upside: +92.44%
Jan 6, 2026
Maintains: Buy
Price Target: $50 → $52
Current: $35.68
Upside: +45.74%
Dec 9, 2025
Maintains: Buy
Price Target: $8 → $12
Current: $10.77
Upside: +11.42%
Nov 10, 2025
Maintains: Buy
Price Target: $136 → $140
Current: $90.54
Upside: +54.63%
Nov 6, 2025
Maintains: Buy
Price Target: $72 → $73
Current: $99.00
Upside: -26.26%
Nov 5, 2025
Maintains: Buy
Price Target: $3 → $9
Current: $1.87
Upside: +381.28%
Nov 3, 2025
Reiterates: Neutral
Price Target: $2
Current: $3.10
Upside: -35.48%
Oct 31, 2025
Upgrades: Buy
Price Target: $5
Current: $1.16
Upside: +331.03%
Oct 27, 2025
Upgrades: Buy
Price Target: $12
Current: $7.36
Upside: +63.04%
Oct 16, 2025
Maintains: Buy
Price Target: $8 → $7
Current: $4.22
Upside: +65.88%
Sep 23, 2025
Reiterates: Buy
Price Target: $5
Current: $3.36
Upside: +48.81%
Aug 26, 2025
Maintains: Buy
Price Target: $16 → $14
Current: $10.13
Upside: +38.20%
Aug 22, 2025
Maintains: Buy
Price Target: $41 → $40
Current: $19.40
Upside: +106.19%
Aug 11, 2025
Maintains: Buy
Price Target: $12 → $10
Current: $2.19
Upside: +356.62%
Jul 2, 2025
Maintains: Buy
Price Target: $40 → $48
Current: $27.39
Upside: +75.25%
Mar 20, 2025
Reiterates: Buy
Price Target: $5
Current: $1.56
Upside: +220.51%
Mar 19, 2025
Maintains: Buy
Price Target: $9 → $8
Current: $2.44
Upside: +227.87%
Jan 28, 2025
Reiterates: Neutral
Price Target: n/a
Current: $5.87
Upside: -
May 8, 2024
Maintains: Buy
Price Target: $500 → $200
Current: $19.51
Upside: +925.12%
Mar 21, 2024
Maintains: Buy
Price Target: $1,320 → $240
Current: $0.32
Upside: +73,974.07%
Aug 8, 2023
Reiterates: Buy
Price Target: $150
Current: $0.42
Upside: +35,202.42%
Dec 22, 2021
Maintains: Buy
Price Target: $12 → $11
Current: $6.75
Upside: +62.96%
Nov 24, 2021
Maintains: Buy
Price Target: $50,000 → $45,000
Current: $1.90
Upside: +2,368,321.05%
Jan 7, 2021
Maintains: Buy
Price Target: $19 → $13
Current: $1.51
Upside: +760.93%